Skip to content
van_bortel

Seminar Title

 

Seminar M2 – Risk analysis of the drug development process – focus on the patient

Affiliation

Heymans Institute of Pharmacology and Drug Research Unit Ghent (D.R.U.G.), Ghent University

Country

Belgium

1. Current Status, Position
 
Prof Dr Van Bortel is Professor clinical pharmacology and pharmacotherapy and Head of D.R.U.G., the University Hospital Unit for early phase clinical drug development.
 
2. Education
 
As medical doctor Luc Van Bortel specialized in internal medicine and clinical pharmacology. He obtained a PhD degree at Maastricht University where he was associate professor clinical pharmacology. From 2000 Luc Van Bortel is chairing the clinical pharmacology Unit at Ghent university. He is a certified trainer in clinical pharmacology.
 
3. Research Area
 
He has 28 years experience in early phase clinical drug development. Besides the early phase clinical drug development Luc Van Bortel’s research is situated in the cardiovascular domain, and in arterial research in particular. He is currently president of the ARTERY Society. 
 
Conflict of interest: None
×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.